#USA #New York #drug cost #Andel #CenterWell Pharmacy

Andel Partners with CenterWell Pharmacy to Enhance Medication Accessibility

Andel, renowned as a direct-to-employer medication marketplace, has taken a significant step in its mission to expand the accessibility of affordable medications. In its recent announcement, the company revealed a collaboration with CenterWell Pharmacy, which will act as a dispensing pharmacy for Andel’s new lines of business, particularly in immunology and beyond. This move aims to help employers tackle the escalating costs associated with high-cost medications.

The rising expenditures related to specialty medications have become a pressing issue for employers nationwide. Research by IQVIA indicates that U.S. spending on specialty medications surged by $27 billion in 2024, primarily driven by oncology and immunology treatments. The demand for immunology medicines has escalated dramatically, growing 72% between 2019 and 2024. Reports from Navitus show that targeted immunomodulators were the priciest specialty category, costing employers more than $22 per member per month, which is almost double the amount spent on oncology drugs.

By bridging the gap between employers paying for these costly medications and the manufacturers setting their prices, Andel is filling a crucial role in the healthcare ecosystem. Its innovative marketplace enables employers to provide more economical access to medications outside of traditional pharmacy benefits, which often impose significant financial burdens.

With the help of CenterWell Pharmacy, Andel plans to support the dispensing and home delivery of prescriptions for its expanding direct-to-employer programs. This partnership combines Andel's expertise in connecting plans with manufacturers and CenterWell's capabilities in specialty and home drug delivery, ensuring that employees and their families receive the necessary medications efficiently.

Jay Bregman, the Founder and CEO of Andel, emphasized the importance of this transition by stating, "GLP-1s were just the beginning. Our ambition has always been to transform how employers procure high-cost medications. Employers urgently require solutions to manage their expenditures while providing more treatment options for their workforce. CenterWell enhances our pharmacy capabilities, enabling us to extend this model into immunology and additional therapeutic areas. This alignment allows us to tackle a larger portion of an employer's drug expenses and address a wider array of employee health needs."

The inclusion of immunology and other therapeutic areas signifies Andel's expanding influence in creating a more robust benefits offering for employers. With this development, employers will gain more access to medications through Andel's marketplace, particularly for treatments related to autoimmune diseases and other conditions that demand ongoing care.

As the partnership unfolds, CenterWell Pharmacy will play a pivotal role in the delivery of eligible prescriptions. This collaboration marks a significant leap in Andel's initiative to build a comprehensive marketplace that addresses the diverse prescription drug needs of employers. By integrating CenterWell’s fulfillment services, Andel is poised to expand its reach, supporting its growth into various medication categories and addressing the ever-increasing demand for affordable prescriptions from employers across the country.

Future Implications

Looking ahead, this collaboration represents a transformative shift in how employers can approach medication expenses. As the landscape of healthcare continues to evolve, innovative partnerships like the one between Andel and CenterWell Pharmacy will be crucial in ensuring that employees receive the necessary medications at a more manageable cost. This initiative not only paves the way for better health outcomes but also enables companies to maintain control over their healthcare budgets, ultimately leading to a more sustainable approach to employee health benefits.

Andel continues to prove itself as a forward-thinking player in the healthcare market, with a firm commitment to lowering medication costs while enhancing access for those who need it most. The impact of this collaboration is bound to be felt across various sectors as employers seek innovative solutions to confront their rising healthcare challenges.